Archive

Year: 2026

  • The new politics – and how you can prepare your business for the risks and opportunities ahead

    May 11, 2026

    By Charley Green What a weekend. UK politics is wide open. The local election results mark an inflection point for the two-party system in British politics which has been the norm for the past century. What's changed We’re seeing a seismic shift in the political landscape as we know it. From stability to instability. From the politics of consensus to the politics of self-interest and division. From one single voice to many powerful voices. Our...

  • Driving Trust in the Age of Agentic AI

    May 8, 2026

    In an era of autonomous systems, human adoption of agentic AI is stalling not because of lack of capability, but because of lack of trust from employees, customers, and internal leadership. Across business today, there is fundamental tension: workforces are fearful they are "building their own coffins," anxious that AI will eliminate their roles entirely. Yet this narrative is far from the truth. The businesses that will win in the agentic AI revolution are those...

  • FleishmanHillard UK announces new leadership to drive bold push forward

    April 30, 2026

    Ahead of its integration with Porter Novelli in the UK, FleishmanHillard today announced its new leadership team for the combined agency.  As it comes together with PN, FH UK will continue to evolve its team and capabilities to provide its clients with the best senior advisory and modern communications campaigning and delivery, enabled by AI and recognising the increasingly complex and fragmented landscape. The new team offers outstanding depth across sectors, first-rate senior advisors, and forward-looking leaders to drive FH’s on-going transformation. It is drawn from...

  • Lucy Kenyon-Jones appointed as UK Chair of Corporate Affairs

    April 30, 2026

    FleishmanHillard UK today announces the appointment of Lucy Kenyon-Jones as UK Chair of Corporate Affairs and strategy lead in the London office. Joining in September, she represents another big step forward in FH’s advisory and campaigning capabilities.  Kenyon-Jones is a seasoned leader in digital strategy, campaigning and integrated communications, bringing extensive experience advising organisations on complex communications, reputation and transformation challenges. In her new role, Kenyon-Jones will enable growth across the business and provide senior strategic counsel to clients, with a particular focus on Corporate Affairs, working alongside Jud Moore, who remains in her role...

  • Event: The Great Healthcare Debate – 12 May

    April 23, 2026

    London, 12 May 2026 - 5pm BST   Join us on 12th May for the Great Healthcare Debate: In a world of AI generated healthcare information, how do we protect the truth? AI is rapidly reshaping how healthcare information is discovered, interpreted and shared – not only by patients and the public, but increasingly by healthcare professionals too. To explore this defining challenge for the future of the healthcare industry, FleishmanHillard and The Pharma Letter invite you to join...

  • The Era of Intentional Fragmentation

    March 30, 2026

    At first glance, it looks like chaos.   For years, starling murmurations baffled scientists. Thousands of birds wheeled across the sky, appearing unpredictable to the naked eye. Until closer study revealed something else: that each movement followed simple, deliberate rules. What looks like chaos is, in fact, curated.   Digital audience behaviour today is following a similar pattern. What appears as scattered platform fragmentation is actually audiences deliberately engineering their own information ecosystems as a result of declining trust, platform bloat, AI-generated noise, and...

  • Culture Report 2026

    March 23, 2026

      What do extended consumer lifespans mean for brands? And how can they show up for consumers in the right way? We’re entering an era where wellbeing is shaped not by youth, but by longer lives, evolving identities and a global shift toward prevention and longevity.  The wellness economy is booming, reaching $6.8T in 2024 and forecasted to hit $9.8T by 2029. The demographic signal is clear: the number of people aged 100+ is projected to rise from roughly...

  • UK ‘Less Healthy Food’ Advertising Restrictions – What They Really Mean For Business

    March 9, 2026

    By Liam McCloy, Head of Public Affairs, EMEA Food Agribusiness Beverage Lead The UK advertising restrictions relating to less healthy food (LHF) products on broadcast and paid online channels that went into effect at the beginning of 2026 represent the latest (but not the last) round of regulations imposed on the food and drink marketing. Much of the response to date has focused on what they do and don’t cover and how to exploit or...

  • The Patient Engagement Gap Your Competitors Are Closing

    February 27, 2026

    By Barry Sudbeck and Laura Musgrave Here’s a question more pharma executives are asking: does patient engagement deliver measurable value, or is it primarily reputational?  It’s a fair question.  In an era where pharmaceutical innovation must demonstrate its value not only through clinical efficacy but also through demonstrated patient relevance, the question is no longer ‘whether’ to engage patients – it’s whether that engagement translates into an advantage.  New research from FleishmanHillard’s Global Health & Life Sciences group suggests it may. Released in recognition of Rare Disease Day, The Patient...

  • FleishmanHillard UK appoints Lou Dalton as Health & Life Sciences Senior Partner, strengthening senior counsel for a rapidly evolving sector and fuelling further growth

    February 16, 2026

    FleishmanHillard UK today announces the appointment of Lou Dalton as Senior Partner for Health & Life Sciences, in a significant move to enhance senior advisory capacity within its largest and fastest-growing team at a time of heightened scrutiny, system pressure and transformation across the sector. Joining on Wednesday, Dalton will play a leading role in FleishmanHillard UK’s Health & Life Sciences sector which provides a broad range of strategic consultancy services including product and corporate...